Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Kardiologiia ; 55(1): 82-87, 2015 Jan.
Artículo en Ruso | MEDLINE | ID: mdl-28294834

RESUMEN

Surgical aortic valve replacement is the standard therapy for severe aortic valve stenosis, however one third of patients are rejected because of high surgical risk. Under medical treatment alone these patients have a very poor prognosis with a high mortality rate. We present a case of 70-year-old male patient with degenerative symptomatic critical aortic stenosis and chronic lymphocytic leukemia. Due to recurrence.

2.
Leuk Lymphoma ; 48(5): 912-22, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17487735

RESUMEN

Mutational status of immunoglobulin variable region genes (VH-genes) is known as the strongest predictor of long term prognosis in B-CLL. However, applications in the routine clinical practice are time consuming, and therefore some other predictions are required. In this study, we have compared prognostic values of real time PCR quantification of the expression levels of four genes previously shown to be differentially expressed in V(H)-unmutated and mutated B-CLL subtypes: ZAP-70, ZBTB20, DMD and LPL. The study included 134 B-CLL patients. Expression levels of LPL and DMD genes were significantly correlated to mutational status, while expression levels of of ZAP-70 gene correlated only in CD19+ selected cases (N = 40). No correlation was observed for ZBTB20 gene. Expression levels of LPL and DMD predicted overall survival in the entire cohort of patients. Prognostic values of LPL gene expression levels were significant even for CLL patients with stage A. Quantitative RT-PCR assays for measuring LPL gene expression are robust enough to be introduced into routine clinical practice.


Asunto(s)
Distrofina/biosíntesis , Regulación Neoplásica de la Expresión Génica , Leucemia de Células B/metabolismo , Leucemia Linfocítica Crónica de Células B/metabolismo , Lipoproteína Lipasa/biosíntesis , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Leucemia de Células B/mortalidad , Leucemia Linfocítica Crónica de Células B/mortalidad , Leucocitos Mononucleares/metabolismo , Masculino , Persona de Mediana Edad , Pronóstico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA